BRAIN Biotech AG (LON:0RFI)
London · Delayed Price · Currency is GBP · Price in EUR 3.030
+0.080 (2.71%)
At close: Dec 12, 2025
BRAIN Biotech AG Market Cap
BRAIN Biotech AG has a market cap or net worth of 57.03 million as of December 12, 2025. Its market cap has decreased by -1.71% in one year.
Market Cap
57.03M
Enterprise Value
47.77M
Revenue
45.95M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.03
Market Cap Chart
Since February 9, 2016, BRAIN Biotech AG's market cap has decreased from 116.58M to 57.03M, a decrease of -51.08%. That is a compound annual growth rate of -7.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 12, 2025 | 57.03M | -11.32% |
| Dec 30, 2024 | 64.31M | -7.32% |
| Dec 29, 2023 | 69.39M | -38.69% |
| Dec 30, 2022 | 113.17M | -33.61% |
| Dec 30, 2021 | 170.45M | 5.04% |
| Dec 30, 2020 | 162.28M | -2.55% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Feb 9, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 210.77B |
| HSBC Holdings | 183.12B |
| Shell | 157.00B |
| Unilever | 106.54B |
| Rio Tinto Group | 94.72B |
| British American Tobacco p.l.c. | 93.57B |
| Rolls-Royce Holdings | 92.58B |
| GSK plc | 72.41B |